Pharma Journalist - Page 2 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Remix Therapeutics to Merge With Passage Bio

Oura, LillyDirect Partner to Support GLP-1 Patients

Lilly Completes Centessa Acquisition to Advance Narcolepsy Treatments

Bayer Partners With Iambic to Accelerate AI Drug Discovery

Lonza, InduPro Partner to Advance Next-Generation Cancer Therapies

Haisco Licenses Two Drug Candidates to Nuvectis

Combotope, Boehringer Partner on Cancer Antibody Research

Abbisko, Lilly Expand Drug Discovery Partnership

Boehringer Advances Phase III Cancer Precision Medicine Trials

Voro and Alloy Partner on Safer Cancer Immunotherapies